5-Year Outcomes After Left Atrial Appendage Closure

医学 心房颤动 华法林 随机对照试验 心脏病学 临床终点 内科学 外科 冲程(发动机) 机械工程 工程类
作者
Vivek Y. Reddy,Shephal K. Doshi,Saibal Kar,Douglas Gibson,Matthew J. Price,Kurt Huber,Rodney Horton,Maurice Buchbinder,Petr Neužil,Nicole Gordon,David R. Holmes
出处
期刊:Journal of the American College of Cardiology [Elsevier]
卷期号:70 (24): 2964-2975 被引量:803
标识
DOI:10.1016/j.jacc.2017.10.021
摘要

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, St. Paul, Minnesota) was equivalent to warfarin for preventing stroke in atrial fibrillation, but had a high rate of complications. In a second randomized trial, PREVAIL (Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy), the complication rate was low. The warfarin cohort experienced an unexpectedly low ischemic stroke rate, rendering the efficacy endpoints inconclusive. However, these outcomes were based on relatively few patients followed for a relatively short time. The final results of the PREVAIL trial, both alone and as part of a patient-level meta-analysis with the PROTECT AF trial, are reported with patients in both trials followed for 5 years. PREVAIL and PROTECT AF are prospective randomized clinical trials with patients randomized 2:1 to LAAC or warfarin; together, they enrolled 1,114 patients for 4,343 patient-years. Analyses are by intention-to-treat, and rates are events per 100 patient-years. For the PREVAIL trial, the first composite coprimary endpoint of stroke, systemic embolism (SE), or cardiovascular/unexplained death did not achieve noninferiority (posterior probability for noninferiority = 88.4%), whereas the second coprimary endpoint of post-procedure ischemic stroke/SE did achieve noninferiority (posterior probability for noninferiority = 97.5%); the warfarin arm maintained an unusually low ischemic stroke rate (0.73%). In the meta-analysis, the composite endpoint was similar between groups (hazard ratio [HR]: 0.820; p = 0.27), as were all-stroke/SE (HR: 0.961; p = 0.87). The ischemic stroke/SE rate was numerically higher with LAAC, but this difference did not reach statistical significance (HR: 1.71; p = 0.080). However, differences in hemorrhagic stroke, disabling/fatal stroke, cardiovascular/unexplained death, all-cause death, and post-procedure bleeding favored LAAC (HR: 0.20; p = 0.0022; HR: 0.45; p = 0.03; HR: 0.59; p = 0.027; HR: 0.73; p = 0.035; HR: 0.48; p = 0.0003, respectively). These 5-year outcomes of the PREVAIL trial, combined with the 5-year outcomes of the PROTECT AF trial, demonstrate that LAAC with Watchman provides stroke prevention in nonvalvular atrial fibrillation comparable to warfarin, with additional reductions in major bleeding, particularly hemorrhagic stroke, and mortality. (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation; NCT00129545; and Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy; NCT01182441)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可可可11完成签到 ,获得积分10
1秒前
Kriemhild完成签到,获得积分10
1秒前
zz完成签到,获得积分10
2秒前
小不溜完成签到 ,获得积分10
3秒前
精明的飞槐完成签到 ,获得积分10
9秒前
柏小霜完成签到 ,获得积分10
12秒前
三金脚脚完成签到 ,获得积分10
22秒前
王肥肥完成签到 ,获得积分10
26秒前
不敢装睡完成签到,获得积分10
27秒前
29秒前
Raul完成签到 ,获得积分10
29秒前
Eliii完成签到 ,获得积分10
30秒前
科研通AI2S应助资紫丝采纳,获得10
34秒前
满意之玉发布了新的文献求助10
35秒前
满意之玉完成签到,获得积分10
41秒前
朴实问筠完成签到 ,获得积分10
41秒前
怡然的一凤完成签到 ,获得积分10
41秒前
王俊凯的科妍通完成签到 ,获得积分10
43秒前
研友_ZzrWKZ完成签到 ,获得积分10
45秒前
slsdianzi完成签到,获得积分10
56秒前
physicalproblem完成签到,获得积分10
57秒前
rayzhanghl完成签到,获得积分10
58秒前
松松包完成签到,获得积分10
58秒前
帅气的祥完成签到,获得积分10
59秒前
1分钟前
EiketsuChiy完成签到 ,获得积分0
1分钟前
书生也是小郎中完成签到 ,获得积分10
1分钟前
二十八画生完成签到 ,获得积分10
1分钟前
一心完成签到,获得积分10
1分钟前
眠眠清完成签到 ,获得积分10
1分钟前
优雅的千雁完成签到,获得积分10
1分钟前
昌化古天乐完成签到 ,获得积分10
1分钟前
Phoenix ZHANG完成签到 ,获得积分10
1分钟前
聚乙二醇完成签到 ,获得积分10
1分钟前
经纲完成签到 ,获得积分0
1分钟前
1分钟前
FashionBoy应助科研通管家采纳,获得10
1分钟前
薰硝壤应助科研通管家采纳,获得10
1分钟前
Jasper应助科研通管家采纳,获得10
1分钟前
天天开心完成签到 ,获得积分10
1分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709891
关于积分的说明 7418319
捐赠科研通 2354494
什么是DOI,文献DOI怎么找? 1246122
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921